文章摘要
范家宏,吴军发,郭君,等.佩戴说话瓣膜对意识障碍气管切开患者呼吸功能的影响[J].中华物理医学与康复杂志,2026,48(10):911-916
佩戴说话瓣膜对意识障碍气管切开患者呼吸功能的影响
  
DOI:10.3760/cma.j.cn421666-20251213-01109
中文关键词: 意识障碍  气管切开  说话瓣膜  呼吸功能
英文关键词: Disorder of consciousness  Tracheotomy  Speech valve  Respiratory function
基金项目:河南省医学科技攻关项目(LHGJ20230398)
作者单位
范家宏 郑州大学第五附属医院康复科,郑州 450000 
吴军发 上海复旦大学附属华山医院,上海市 200000 
郭君 郑州大学第五附属医院康复科,郑州 450000 
关晨霞 郑州大学第五附属医院康复科,郑州 450000 
乐琳 郑州大学第五附属医院康复科,郑州 450000 
方明珠 郑州大学第五附属医院康复科,郑州 450000 
刘娟 郑州大学护理与健康学院,郑州 450000 
仝祎冉 郑州大学护理与健康学院,郑州 450000 
马改丽 郑州大学第五附属医院康复科,郑州 450000 
摘要点击次数: 466
全文下载次数: 419
中文摘要:
  目的 观察佩戴说话瓣膜对意识障碍气管切开患者呼吸功能的影响。 方法 选取在我院康复治疗的意识障碍气管切开患者40例作为观察对象,采用随机数字表法将其分为观察组及对照组,每组20例。对照组患者给予常规康复干预,包括体位管理、关节活动训练、吞咽训练、针灸理疗、呼吸训练、气道廓清等,观察组在此基础上佩戴说话瓣膜,2组均治疗8周。于治疗前、后对2组患者进行疗效评定,采用膈肌移动度(DE)及膈肌增厚率(DTF)指标评估呼吸功能;采用标准吞咽功能评价量表(SSA)评估吞咽功能;采用白卡试验(WCT)评估咳嗽能力;采用临床肺部感染量表(CPIS)评估肺部感染情况,并统计2组患者拔管时间及不良事件发生率。 结果 治疗前,2组患者呼吸功能、吞咽功能、咳嗽能力及肺部感染情况组间差异均无统计学意义(P>0.05);治疗后2组患者DE及DTF均较治疗前明显增加(P<0.05),并且观察组上述指标改善幅度均显著优于对照组(P<0.05);治疗后2组患者SSA、CPIS评分均较治疗前明显降低(P<0.05),并且观察组上述指标降低幅度均显著优于对照组(P<0.05);治疗后2组患者WCT评级均较治疗前明显提高(P<0.05),并且观察组WCT评级亦显著优于对照组(P<0.05);此外观察组拔管时间较对照组明显缩短(P<0.05),治疗期间2组患者均未出现严重不良事件。 结论 佩戴说话瓣膜可改善意识障碍气管切开患者呼吸功能,还能增强吞咽功能及咳嗽能力,从而降低肺部感染风险,促进气管套管早日拔除,并且治疗过程中安全性较好,所有患者均未出现严重不良反应。
英文摘要:
    Objective To observe the effect of a speaking valve on respiratory function in tracheostomized patients with consciousness disorders. Methods Forty tracheostomized patients with consciousness disorders who received rehabilitation treatment in our hospital were selected and divided into an observation group and a control group using a random number table, with 20 cases in each group. The control group received conventional rehabilitation interventions, including positioning management, joint mobilization, swallowing training, acupuncture and physiotherapy, respiratory training, and airway clearance. On this basis, the observation group wore a speaking valve for a total of 8 weeks. Efficacy was assessed in both groups before and after treatment. Respiratory function was evaluated by diaphragmatic excursion (DE) and diaphragmatic thickening fraction (DTF); swallowing function was assessed using the Standardized Swallowing Assessment (SSA); cough ability was evaluated by the White Card Test (WCT); and pulmonary infection status was assessed using the Clinical Pulmonary Infection Score (CPIS). The decannulation time and the incidence of adverse events were also recorded. Results Before treatment, there were no significant differences in respiratory function, swallowing function, cough ability, or pulmonary infection status between the two groups(P>0.05).After treatment, both DE and DTF increased significantly compared with those before treatment in both groups, and the improvement in the observation group was significantly greater than that in the control group (P<0.05).After treatment, the SSA and CPIS scores decreased significantly in both groups(P<0.05).and the reduction in the observation group was significantly greater than that in the control group(P<0.05),After treatment, the WCT grades improved significantly in both groups(P<0.05),and the observation group demonstrated significantly better WCT grades than the control group. The decannulation time in the observation group was significantly shorter than that in the control group(P<0.05).No serious adverse events occurred in either group during the treatment period. Conclusions Wearing a speaking valve can improve respiratory function, enhance swallowing function and cough ability in tracheostomized patients with consciousness disorders, thereby reducing the risk of pulmonary infection and promoting tracheostomy tube decannulation, with good safety and no obvious adverse reactions during treatment.
查看全文   下载PDF阅读器  HTML全文
关闭